No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
Medical University of South Carolina · Other
Who this trial is looking for
This trial is looking for adults with elevated depression symptoms who want to try a new way of treatment using a smartphone app and telehealth sessions. Participants will use a tool called Moodivate and may get additional support from a healthcare provider.
Are You a Good Fit for This Trial?
You may be able to join if
I have elevated depression symptoms.
I am 18 years or older.
I own an iOS or Android smartphone.
I am willing to use the Moodivate app.
I am willing to engage in telehealth treatment.
I have access to email or text messaging.
I speak English fluently.
You may not be able to join if
I am currently receiving depression treatment.
I have current suicidal thoughts.
I do not live in South Carolina.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This pilot, three-arm randomized clinical trial (N=40; 2:1:1) will evaluate the feasibility and preliminary efficacy of a digitally enhanced stepped-care approach for depression treatment in primary care. Participants will be randomized to: (1) stepped-care beginning with a self-guided Behavioral Activation app (Moodivate), with stepping to clinician-delivered telebehavioral health Behavioral Acti…
This pilot, three-arm randomized clinical trial (N=40; 2:1:1) will evaluate the feasibility and preliminary efficacy of a digitally enhanced stepped-care approach for depression treatment in primary care. Participants will be randomized to: (1) stepped-care beginning with a self-guided Behavioral Activation app (Moodivate), with stepping to clinician-delivered telebehavioral health Behavioral Activation at Week 2 based on app engagement and early PHQ-9 change; (2) telebehavioral health Behavioral Activation; or (3) Moodivate alone. The primary endpoint is feasibility of the stepped-care approach, defined as continued engagement after stepping (≥1 Moodivate use/week for \>4 weeks or ≥4 therapy sessions). The secondary endpoint is change in PHQ-9 scores from baseline through Week 12. The study will be conducted within MUSC Primary Care clinics across South Carolina using remote screening, e-consent, and REDCap assessments.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* elevated depression symptoms (score of \>=10 on the PHQ-9)
* age \>=18 years
* owns an iOS or Android smartphone
* willing to use Moodivate
* willing to engage in telehealth depression treatment
* access to email or text messaging (for assessments)
* English fluency
Exclusion…
Inclusion Criteria:
* elevated depression symptoms (score of \>=10 on the PHQ-9)
* age \>=18 years
* owns an iOS or Android smartphone
* willing to use Moodivate
* willing to engage in telehealth depression treatment
* access to email or text messaging (for assessments)
* English fluency
Exclusion Criteria:
* current receipt of psychosocial depression treatment (e.g., individual or group therapy)
* current suicidal ideation, defined as a response \>=1 ("several days") on PHQ-9 item nine
* does not live in the state of South Carolina
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.